Use of intranasal esketamine in a girl with treatment-resistant depression and autism spectrum disorders: a case report.
EXCLI journal 2022 Miriam Olivola, Vincenzo Arienti, Nicola Bassetti et al.
Major depression is a common comorbidity in autism spectrum disorder (ASD), often difficult to identify and to treat. Autistic subjects are more at risk for suicidal thoughts and behaviors compared to typically developing peers. Unfortunately, ASD individuals are more frequently treatment-resistant and often show side-effects which reduce efficacy. Intranasal esketamine has been recently...
DOI: 10.17179/excli2022-4694 (opens in new tab)
Full text (opens in new tab)
Depression
Esketamine
Autism spectrum disorders
Treatment-resistant